Martinostat
Martinostat is an experimental drug candidate that is being studied for its potential use in the treatment of various diseases. It is a small molecule inhibitor of histone deacetylases (HDACs), a group of enzymes that play a key role in the regulation of gene expression. Martinostat has been shown to have potent activity against HDACs, and it is thought that it may have potential therapeutic applications in diseases where these enzymes are dysregulated, such as cancer and neurological disorders.
Mechanism of Action
Martinostat works by inhibiting the activity of HDACs. These enzymes are responsible for removing acetyl groups from histones, which are proteins that help package DNA into a compact, organized structure within the cell nucleus. By inhibiting HDACs, Martinostat can increase the acetylation of histones, leading to changes in the structure of the chromatin and the regulation of gene expression. This can potentially affect the growth and survival of cells, making Martinostat a potential therapeutic agent for diseases characterized by abnormal cell growth and survival, such as cancer.
Clinical Development
Martinostat is currently in the early stages of clinical development. Preclinical studies have shown that it has potent activity against HDACs and can induce changes in gene expression that are associated with cell growth and survival. However, further studies are needed to determine the safety and efficacy of Martinostat in humans.
Potential Applications
Given its mechanism of action, Martinostat may have potential applications in a variety of diseases where HDACs are dysregulated. This includes various types of cancer, as well as neurological disorders such as Huntington's disease and Alzheimer's disease. However, more research is needed to fully understand the potential therapeutic applications of Martinostat.
See Also
References
<references />
Ad. Transform your life with W8MD's Budget GLP-1 injections from $49.99


W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $49.99 for the starting dose of Semaglutide and $65.00 for Tirzepatide.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


